Evidence map›Paper›PMID 39589744›Full record

ArticleJAMA network open2024

Collaborative Care Model for Patients With Opioid Use Disorder and Mental Illness.

Katherine E Watkins, Rebecca Weir, Lia Pak, Beth Ann Griffin, Amber Griffo, Allison Trosclair Sutherland, Colleen M McCullough, Lisa S Meredith, Michael Schoenbaum, Miriam Komaromy and 2 more

Abstract read
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Katherine E WatkinsRAND Corporation, Santa Monica, California.
Rebecca WeirRAND Corporation, Arlington, Virginia.
Lia PakRAND Corporation, Boston, Massachusetts.
Beth Ann GriffinRAND Corporation, Arlington, Virginia.
Amber GriffoDepartment of Family and Community Medicine, University of New Mexico, Albuquerque.
Allison Trosclair SutherlandFirst Choice Community Healthcare, Albuquerque, New Mexico.
Colleen M McCulloughRAND Corporation, Santa Monica, California.
Lisa S MeredithRAND Corporation, Santa Monica, California.
Michael SchoenbaumDivision of Services and Intervention Research, National Institute of Mental Health, Bethesda, Maryland.
Miriam KomaromyDivision of General Internal Medicine, Department of Medicine, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts.
Valerie CarrejoDepartment of Family and Community Medicine, University of New Mexico, Albuquerque.
Karen Chan OsillaDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California.

Funding

Improving Access and Treatment for Co-occurring Opioid Use Disorders and Mental Illness - Recruitment ExtensionUF1MH121954 · NIMH · RAND CORPORATION · PI KOMAROMY, MIRIAM, WATKINS, KATHERINE E · 2019 to 2024
$15.8M
NIMH NIH HHS UF1 MH121954
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39589744
PMCPMC11600228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.